LOXXESS has fully acquired LOXXESS Pharma

6. October 2021

In August 2021,LOXXESS, the specialized logistics service provider, expanded its long-standing participation as the largest shareholder of LOXXESS Pharma GmbH and now holds 100% of the shares in the logistics specialist that specializes in distributing pharmaceuticals. The jobs, processes and services at the two companies will not be affected by this change. Nevertheless, you can expect to see an expansion in our service capabilities and synergies for our customers.

Image captions (l to r.): LOXXESS director Christina Thurner; Dr Tilman Spaethe, Finance, HR, Service Center managing director; Dr Beate Grudzus-Zager, Manufacturing, Quality, Regulatory Compliance managing director and Johann Strobl, Operations managing director at LOXXESS Pharma. Copyright: Loxxess AG, Loxxess Pharma.

LOXXESS AG, the logistics and fulfillment service provider from Tegernsee, has also acquired all of the shares of our previously co-invested partners, Aenova Holding GmbH, Alloga S.à.r.l. and Haupt Pharma Wolfratshausen GmbH. LOXXESS Pharma has its headquarters in Neutraubling near Regensburg and it provides modular logistics and distribution solutions for customers from the pharmaceutical industry, the medtech sector as well as the premium cosmetics market and it currently employs 180 people at three facilities in Bavaria. Around 1.2 billion pharmaceutical packages are handled every year. LOXXESS AG also has a strong network and many years of expertise from working with customers in the pharmaceutical logistics sector, e.g.with HARTMANN at our Henstedt-Ulzburg facility.

“This takeover will enable us to bundle the strengths and expertise of both companies and create new synergies. Given that the complexity of pharmaceutical products will increase and the market will continue to grow in the future, both companies are now superbly positioned for planned facility expansions”, explained LOXXESS director, Christina Thurner.  

Since it was founded in 2000, LOXXESS Pharma, like LOXXESS AG, has grown organically whilst providing high-level services, as proven by its commitment to complying with the GDP (Good Distribution Practice) and GSP (Good Storage Practice) guidelines. LOXXESS Pharma is already active throughout Europe: The specialized service provider has modular access to services in 15 European countries through its integration in the Alloga Europe network. These services and the network will be expanded in the future to include other LOXXESS facilities in Germany, the Czech Republic and Poland.

Otto Prange, previous chairman of the advisory board who was representing Aenova, commented on the transaction as follows: “Merging the shares into a single holding under the proven expertise of the LOXXESS shareholders will bring important advantages to LOXXESS Pharma. This will enable the company to further expand its multi-national distribution solutions in the future. It will also open up new market opportunities for the joint customers – so in this respect the merging of the shares by LOXXESS is a logical and correct step“.

On behalf of his management colleagues, Dr Beate Grudzus-Zager and Dr Tilman Spaethe, Johann Strobl, the Operations | Digital | Sales managing director at LOXXESS Pharma said: “Operational cooperation with LOXXESS can be further expanded as a result of them acquiring all of the shares. At the same time, we will continue to operate independently in our segment as a specialized service provider for the pharmaceutical market and we will be able to meet future customer requirements with innovative concepts and services”.

LOXXESS AG employs around 2,600 people at its 26 facilities in Germany, Poland and the Czech Republic. The logistics service provider has a total of 600,000 m2 of covered warehouse space and had a turnover of 175 million euros in 2020.